Published in Trends Pharmacol Sci on February 21, 2006
Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans R Soc Lond B Biol Sci (2007) 2.66
When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol (2009) 2.59
The role of neuronal complexes in human X-linked brain diseases. Am J Hum Genet (2007) 1.71
Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior. Neuropsychopharmacology (2010) 1.51
Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder. J Psychiatry Neurosci (2010) 1.19
A novel touchscreen-automated paired-associate learning (PAL) task sensitive to pharmacological manipulation of the hippocampus: a translational rodent model of cognitive impairments in neurodegenerative disease. Psychopharmacology (Berl) (2009) 1.19
Impulsive behaviour induced by both NMDA receptor antagonism and GABAA receptor activation in rat ventromedial prefrontal cortex. Psychopharmacology (Berl) (2011) 1.14
mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration. Behav Neurosci (2011) 1.10
Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology (2010) 1.10
Low striatal glutamate levels underlie cognitive decline in the elderly: evidence from in vivo molecular spectroscopy. Cereb Cortex (2008) 1.08
Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood. Eur J Neurosci (2012) 1.04
Adolescent ethanol exposure: does it produce long-lasting electrophysiological effects? Alcohol (2010) 1.04
Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory. Neurobiol Learn Mem (2011) 1.01
Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory. Neuropsychopharmacology (2011) 0.98
How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res Health (2008) 0.96
MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function. FASEB J (2008) 0.95
Glutamatergic targets for enhancing extinction learning in drug addiction. Curr Neuropharmacol (2010) 0.95
Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry. Neuroscience (2010) 0.93
The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats. Psychopharmacology (Berl) (2012) 0.92
Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society. Behav Pharmacol (2010) 0.87
Regulation of the NMDA receptor-mediated synaptic response by acetylcholinesterase inhibitors and its impairment in an animal model of Alzheimer's disease. Neurobiol Aging (2007) 0.86
Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's disease. Genome Biol (2007) 0.86
Effects of adolescent ethanol exposure on sleep in adult rats. Alcohol (2008) 0.85
Effects of adolescent ethanol exposure on event-related oscillations (EROs) in the hippocampus of adult rats. Behav Brain Res (2010) 0.85
Differential modulation of reinforcement learning by D2 dopamine and NMDA glutamate receptor antagonism. J Neurosci (2014) 0.84
N-methyl-D-aspartic acid receptors on striatal neurons are essential for cocaine cue reactivity in mice. Biol Psychiatry (2010) 0.84
Impaired cognition and attention in adults: pharmacological management strategies. Neuropsychiatr Dis Treat (2007) 0.83
Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats. Psychopharmacology (Berl) (2014) 0.83
Gene specific modifications unravel ethanol and acetaldehyde actions. Front Behav Neurosci (2013) 0.82
Communication networks in the brain: neurons, receptors, neurotransmitters, and alcohol. Alcohol Res Health (2008) 0.82
In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging. Neurobiol Aging (2012) 0.82
Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. Behav Sci (Basel) (2014) 0.79
Investigating glutamatergic mechanism in attention and impulse control using rats in a modified 5-choice serial reaction time task. PLoS One (2014) 0.79
Glutamatergic autoencephalitides: an emerging field. J Neural Transm (Vienna) (2014) 0.78
Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study. J Neurodev Disord (2013) 0.77
Pu-erh Tea Protects the Nervous System by Inhibiting the Expression of Metabotropic Glutamate Receptor 5. Mol Neurobiol (2016) 0.76
Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy ((1)H MRS). J Neurodev Disord (2014) 0.76
Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission. Transl Psychiatry (2015) 0.76
The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach. BMC Psychiatry (2010) 0.75
Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis. Int J Tryptophan Res (2013) 0.75
Optogenetic Stimulation of Prefrontal Glutamatergic Neurons Enhances Recognition Memory. J Neurosci (2016) 0.75
Ketamine: differential neurophysiological dynamics in functional networks in the rat brain. Transl Psychiatry (2017) 0.75
Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors. PLoS One (2017) 0.75
Standardization of formulations for the acute amino acid depletion and loading tests. J Psychopharmacol (2015) 0.75
A synaptic model of memory: long-term potentiation in the hippocampus. Nature (1993) 29.13
Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol (1997) 10.26
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature (1986) 7.10
Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J Physiol (1983) 6.04
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry (2004) 5.26
Behavioral and neural analysis of extinction. Neuron (2002) 4.53
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci (2002) 4.52
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A (1986) 3.97
A modern learning theory perspective on the etiology of panic disorder. Psychol Rev (2001) 3.59
Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus (1999) 3.55
Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci (1992) 3.40
Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys. J Neurosci (1993) 3.07
Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior. J Neurosci (2001) 2.96
Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther (2001) 2.55
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry (1999) 2.44
Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat Neurosci (1999) 2.32
Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) (2005) 2.25
Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature (1990) 2.17
Perceptual-mnemonic functions of the perirhinal cortex. Trends Cogn Sci (1999) 2.16
Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci U S A (2005) 1.94
Glutamate-receptor-mediated encoding and retrieval of paired-associate learning. Nature (2003) 1.74
Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology (Berl) (2004) 1.69
Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. Behav Neurosci (2003) 1.69
A within-subjects, within-task demonstration of intact spatial reference memory and impaired spatial working memory in glutamate receptor-A-deficient mice. J Neurosci (2003) 1.58
D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry (2005) 1.53
Glutamate receptors in perirhinal cortex mediate encoding, retrieval, and consolidation of object recognition memory. J Neurosci (2005) 1.45
NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: immunization against amnesia by context preexposure. Behav Neurosci (1994) 1.38
Memory enhancement: the search for mechanism-based drugs. Nat Neurosci (2002) 1.34
Selective impairment of long-term but not short-term conditional fear by the N-methyl-D-aspartate antagonist APV. Behav Neurosci (1992) 1.31
Distinct contributions of hippocampal NMDA and AMPA receptors to encoding and retrieval of one-trial place memory. J Neurosci (2005) 1.31
Double dissociation of hippocampal and dorsal-striatal memory systems by posttraining intracerebral injections of 2-amino-5-phosphonopentanoic acid. Behav Neurosci (1997) 1.30
D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav (1989) 1.29
Chemical excitation of spinal neurones. Nature (1959) 1.14
New therapeutic frontiers for metabotropic glutamate receptors. Curr Top Med Chem (2005) 1.13
Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 impairs acquisition but not performance of discriminated approach to an appetitive CS. Behav Neural Biol (1994) 1.05
The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesic responses in the rat. Q J Exp Psychol B (1994) 1.01
A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients. Psychopharmacology (Berl) (2004) 1.01
Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am J Psychiatry (1999) 0.98
l-glutamate as a central neurotransmitter: looking back. Biochem Soc Trans (2000) 0.95
The competitive NMDA antagonist AP5, but not the non-competitive antagonist MK801, induces a delay-related impairment in spatial working memory in rats. Exp Brain Res (1991) 0.94
Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory. Neuropsychopharmacology (2003) 0.92
D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys. J Pharmacol Exp Ther (1996) 0.91
The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks. Eur Neuropsychopharmacol (1995) 0.85
NMDA receptor antagonists impair memory for nonspatial, socially transmitted food preference. Behav Neurosci (2002) 0.82
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. Eur J Neurosci (2005) 1.13
Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology (2007) 1.01
Chimeras of nurture. Am J Bioeth (2007) 0.79
Women's neuroethics? Why sex matters for neuroethics. Am J Bioeth (2008) 0.75